Updates are available Correction dated 2019-02-04
Click to view Correction: https://doi.org/10.1038/s41591-019-0378-6
-
Authors
Yin, Changjun https://orcid.org/0000-0002-1913-4477
Ackermann, Susanne https://orcid.org/0000-0001-8179-5201
Ma, Zhe
Mohanta, Sarajo K. https://orcid.org/0000-0001-6144-4092
Zhang, Chuankai
Li, Yuanfang
Nietzsche, Sandor
Westermann, Martin
Peng, Li
Hu, Desheng
Bontha, Sai Vineela https://orcid.org/0000-0001-8914-1966
Srikakulapu, Prasad
Beer, Michael
Megens, Remco T. A.
Steffens, Sabine
Hildner, Markus
Halder, Luke D.
Eckstein, Hans-Henning
Pelisek, Jaroslav
Herms, Jochen
Roeber, Sigrun
Arzberger, Thomas
Borodovsky, Anna
Habenicht, Livia
Binder, Christoph J.
Weber, Christian https://orcid.org/0000-0003-4610-8714
Zipfel, Peter F. https://orcid.org/0000-0002-6149-2411
Skerka, Christine https://orcid.org/0000-0003-2374-6473
Habenicht, Andreas J. R. https://orcid.org/0000-0003-2901-3027
- License Information
-
More Information
Article History
Received: 18 September 2018
Accepted: 13 December 2018
First Online: 28 January 2019
Change Date: 4 February 2019
Change Type: Correction
Change Details: In the version of this article originally published, a sentence was erroneously included in the author contributions, and information regarding second shared authorship was missing from the author contributions. The following should not have been included in the author contributions: “C.W. and A.J.R.H. supervised the work presented in Figs. 1, 2, 5, 6; P.Z. and C.S. supervised the work presented in Figs. 3, 4.” Additionally, this sentence should have appeared at the beginning of the author contributions: “These authors contributed equally: C.W., P.F.Z., C.S., and A.J.R.H.” The errors have been corrected in the print, PDF and HTML versions of the article.
Competing interests
: C.Y., A.J.R.H., A.B., S.K.M., S.A., P.F.Z., and C.S. declare competing financial interests. C.Y., S.K.M., and A.J.R.H. are owners of Easemedcontrol R & D GmbH & Co KG Munich, Germany; A.B. is employed by Alnylam Pharmaceuticals Cambridge; Cambridge, MA, USA; C.Y. and A.J.R.H. have been named inventors on a pending patent application related to treatment and diagnosis of unresolvable inflammatory diseases (EP18183584.4); A.B. has been named as an inventor on patent applications related to C5 including PCT publication WO2014160129, and applications and patents based thereon; S.A., P.F.Z., and C.S. have been named inventors on a pending patent application (DE 10 2018 100 377.3).
